The	O
value	O
of	O
lacrimal	B:C0430022
scintillography	I:C0430022
in	O
the	O
assessment	O
of	O
patients	O
with	O
epiphora	O
.	O

The	O
value	O
of	O
lacrimal	O
scintillography	I:C0430022
in	O
the	O
assessment	O
of	O
patients	O
with	O
epiphora	B:C0152227
.	O

PurposeTo	O
assess	O
the	O
influence	O
of	O
dacryoscintillography	B:C0430022
(	O
dacryoscintillography	O
)	O
on	O
the	O
treatment	O
decision	O
for	O
patients	O
with	O
epiphora	O
and	O
clinically	O
patent	I:C0243095
non-functioning	O
lacrimal	O
systems	I:C0022903
.	O

PurposeTo	O
assess	O
the	O
influence	O
of	O
dacryoscintillography	O
(	O
dacryoscintillography	B:C0430022
)	O
on	O
the	O
treatment	O
decision	O
for	O
patients	O
with	O
epiphora	O
and	O
clinically	O
patent	I:C0243095
non-functioning	O
lacrimal	O
systems	I:C0022903
.	O

PurposeTo	O
assess	O
the	O
influence	O
of	O
dacryoscintillography	O
(	O
dacryoscintillography	O
)	O
on	O
the	O
treatment	O
decision	O
for	O
patients	O
with	O
epiphora	B:C0152227
and	O
clinically	O
patent	I:C0243095
non-functioning	O
lacrimal	O
systems	I:C0022903
.	O

PurposeTo	O
assess	O
the	O
influence	O
of	O
dacryoscintillography	O
(	O
dacryoscintillography	O
)	O
on	O
the	O
treatment	O
decision	O
for	O
patients	O
with	O
epiphora	O
and	O
clinically	B:C0243095
patent	I:C0243095
non-functioning	O
lacrimal	O
systems	I:C0022903
.	O

PurposeTo	O
assess	O
the	O
influence	O
of	O
dacryoscintillography	O
(	O
dacryoscintillography	O
)	O
on	O
the	O
treatment	O
decision	O
for	O
patients	O
with	O
epiphora	O
and	O
clinically	O
patent	I:C0243095
non-functioning	O
lacrimal	B:C0022903
systems	I:C0022903
.	O

MethodsA	O
retrospective	B:C0035363
3	I:C0035363
-	I:C0035363
year	I:C0035363
review	I:C0035363
.	O

Inclusion	O
:	O
patients	O
having	O
dacryoscintillography	B:C0430022
for	O
epiphora	O
with	O
delayed	O
tear	I:C0243095
clearance	I:C0243095
,	O
lacrimal	O
system	I:C0243095
patency	I:C0243095
on	I:C0243095
syringing	I:C0243095
,	O
and	O
no	O
visible	O
external	O
cause	O
for	O
watering	O
.	O

Inclusion	O
:	O
patients	O
having	O
dacryoscintillography	O
for	O
epiphora	B:C0152227
with	O
delayed	O
tear	I:C0243095
clearance	I:C0243095
,	O
lacrimal	O
system	I:C0243095
patency	I:C0243095
on	I:C0243095
syringing	I:C0243095
,	O
and	O
no	O
visible	O
external	O
cause	O
for	O
watering	O
.	O

Inclusion	O
:	O
patients	O
having	O
dacryoscintillography	O
for	O
epiphora	O
with	O
delayed	B:C0243095
tear	I:C0243095
clearance	I:C0243095
,	O
lacrimal	O
system	I:C0243095
patency	I:C0243095
on	I:C0243095
syringing	I:C0243095
,	O
and	O
no	O
visible	O
external	O
cause	O
for	O
watering	O
.	O

Inclusion	O
:	O
patients	O
having	O
dacryoscintillography	O
for	O
epiphora	O
with	O
delayed	O
tear	I:C0243095
clearance	I:C0243095
,	O
lacrimal	B:C0243095
system	I:C0243095
patency	I:C0243095
on	I:C0243095
syringing	I:C0243095
,	O
and	O
no	O
visible	O
external	O
cause	O
for	O
watering	O
.	O

Inclusion	O
:	O
patients	O
having	O
dacryoscintillography	O
for	O
epiphora	O
with	O
delayed	O
tear	I:C0243095
clearance	I:C0243095
,	O
lacrimal	O
system	I:C0243095
patency	I:C0243095
on	I:C0243095
syringing	I:C0243095
,	O
and	O
no	O
visible	O
external	O
cause	O
for	O
watering	B:C3257803
.	O

On	O
the	O
basis	O
of	O
regurgitation	O
during	O
syringing	B:C0430882
,	O
tear	O
ducts	I:C0459624
were	O
divided	O
into	O
freely	O
patent	I:C0429498
(	O
FP	O
≤	O
20	O
%	O
)	O
or	O
stenosed	O
.	O

On	O
the	O
basis	O
of	O
regurgitation	O
during	O
syringing	O
,	O
tear	B:C0459624
ducts	I:C0459624
were	O
divided	O
into	O
freely	O
patent	I:C0429498
(	O
FP	O
≤	O
20	O
%	O
)	O
or	O
stenosed	O
.	O

On	O
the	O
basis	O
of	O
regurgitation	O
during	O
syringing	O
,	O
tear	O
ducts	I:C0459624
were	O
divided	O
into	O
freely	B:C0429498
patent	I:C0429498
(	O
FP	O
≤	O
20	O
%	O
)	O
or	O
stenosed	O
.	O

On	O
the	O
basis	O
of	O
regurgitation	O
during	O
syringing	O
,	O
tear	O
ducts	I:C0459624
were	O
divided	O
into	O
freely	O
patent	I:C0429498
(	O
FP	B:C0429498
≤	O
20	O
%	O
)	O
or	O
stenosed	O
.	O

The	O
dacryoscintillography	B:C0430022
results	O
were	O
examined	O
for	O
correlation	O
with	O
symptoms	O
and	O
clinical	O
examination	O
,	O
the	O
influence	O
on	O
decision	O
to	O
proceed	O
to	O
dacryocystorhinostomy	O
(	O
dacryocystorhinostomy	O
)	O
,	O
and	O
the	O
ability	O
to	O
predict	O
the	O
surgical	O
outcome	O
.	O

The	O
dacryoscintillography	O
results	O
were	O
examined	O
for	O
correlation	O
with	O
symptoms	B:C1457887
and	O
clinical	O
examination	O
,	O
the	O
influence	O
on	O
decision	O
to	O
proceed	O
to	O
dacryocystorhinostomy	O
(	O
dacryocystorhinostomy	O
)	O
,	O
and	O
the	O
ability	O
to	O
predict	O
the	O
surgical	O
outcome	O
.	O

The	O
dacryoscintillography	O
results	O
were	O
examined	O
for	O
correlation	O
with	O
symptoms	O
and	O
clinical	O
examination	O
,	O
the	O
influence	O
on	O
decision	O
to	O
proceed	O
to	O
dacryocystorhinostomy	B:C0010931
(	O
dacryocystorhinostomy	O
)	O
,	O
and	O
the	O
ability	O
to	O
predict	O
the	O
surgical	O
outcome	O
.	O

The	O
dacryoscintillography	O
results	O
were	O
examined	O
for	O
correlation	O
with	O
symptoms	O
and	O
clinical	O
examination	O
,	O
the	O
influence	O
on	O
decision	O
to	O
proceed	O
to	O
dacryocystorhinostomy	O
(	O
dacryocystorhinostomy	B:C0010931
)	O
,	O
and	O
the	O
ability	O
to	O
predict	O
the	O
surgical	O
outcome	O
.	O

ResultsA	O
total	O
of	O
242	O
eyes	B:C0015392
were	O
examined	O
.	O

ResultsA	O
total	O
of	O
242	O
eyes	O
were	O
examined	B:C0332128
.	O

The	O
clinical	B:C0332140
diagnosis	I:C0332140
was	O
FP	O
in	O
45.5	O
%	O
,	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
(	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
)	O
in	O
26.4	O
%	O
,	O
and	O
other	O
in	O
3.3	O
%	O
.	O

The	O
clinical	O
diagnosis	I:C0332140
was	O
FP	B:C0429498
in	O
45.5	O
%	O
,	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
(	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
)	O
in	O
26.4	O
%	O
,	O
and	O
other	O
in	O
3.3	O
%	O
.	O

The	O
clinical	O
diagnosis	I:C0332140
was	O
FP	O
in	O
45.5	O
%	O
,	O
nasolacrimal	B:C0238300
duct	I:C0238300
stenosis	I:C0238300
(	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
)	O
in	O
26.4	O
%	O
,	O
and	O
other	O
in	O
3.3	O
%	O
.	O

The	O
clinical	O
diagnosis	I:C0332140
was	O
FP	O
in	O
45.5	O
%	O
,	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
(	O
nasolacrimal	B:C0238300
duct	I:C0238300
stenosis	I:C0238300
)	O
in	O
26.4	O
%	O
,	O
and	O
other	O
in	O
3.3	O
%	O
.	O

The	O
dacryoscintillography	B:C0430022
was	O
normal	O
in	O
30.9	O
%	O
of	O
FP	O
and	O
18.7	O
%	O
of	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
eyes	O
.	O

The	O
dacryoscintillography	O
was	O
normal	O
in	O
30.9	O
%	O
of	O
FP	B:C0429498
and	O
18.7	O
%	O
of	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
eyes	O
.	O

The	O
dacryoscintillography	O
was	O
normal	O
in	O
30.9	O
%	O
of	O
FP	O
and	O
18.7	O
%	O
of	O
nasolacrimal	B:C0238300
duct	I:C0238300
stenosis	I:C0238300
eyes	O
.	O

The	O
dacryoscintillography	O
was	O
normal	O
in	O
30.9	O
%	O
of	O
FP	O
and	O
18.7	O
%	O
of	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
eyes	B:C0015392
.	O

Of	O
the	O
asymptomatic	B:C0231221
eyes	O
,	O
46.7	O
%	O
had	O
an	O
abnormal	O
dacryoscintillography	O
.	O

Of	O
the	O
asymptomatic	O
eyes	B:C0015392
,	O
46.7	O
%	O
had	O
an	O
abnormal	O
dacryoscintillography	O
.	O

Of	O
the	O
asymptomatic	O
eyes	O
,	O
46.7	O
%	O
had	O
an	O
abnormal	O
dacryoscintillography	B:C0430022
.	O

dacryoscintillography	B:C0430022
sensitivity	O
was	O
73.6	O
%	O
and	O
specificity	O
53.3	O
%	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
dacryoscintillography	B:C0430022
results	O
in	O
those	O
with	O
FP	O
or	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
dacryoscintillography	O
results	O
in	O
those	O
with	O
FP	B:C0429498
or	O
nasolacrimal	O
duct	I:C0238300
stenosis	I:C0238300
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
dacryoscintillography	O
results	O
in	O
those	O
with	O
FP	O
or	O
nasolacrimal	B:C0238300
duct	I:C0238300
stenosis	I:C0238300
.	O

dacryocystorhinostomy	B:C0010931
was	O
recommended	O
in	O
39.1	O
%	O
of	O
the	O
symptomatic	O
eyes	O
with	O
abnormal	O
dacryoscintillography	O
.	O

dacryocystorhinostomy	O
was	O
recommended	O
in	O
39.1	O
%	O
of	O
the	O
symptomatic	O
eyes	B:C0231221
with	O
abnormal	O
dacryoscintillography	O
.	O

dacryocystorhinostomy	O
was	O
recommended	O
in	O
39.1	O
%	O
of	O
the	O
symptomatic	O
eyes	O
with	O
abnormal	O
dacryoscintillography	B:C0430022
.	O

DCR	B:C0010931
surgery	I:C0010931
was	O
considered	O
inappropriate	O
in	O
all	O
46	O
eyes	O
with	O
normal	O
dacryoscintillography	O
.	O

DCR	O
surgery	I:C0010931
was	O
considered	O
inappropriate	O
in	O
all	O
46	O
eyes	B:C0231221
with	O
normal	O
dacryoscintillography	O
.	O

DCR	O
surgery	I:C0010931
was	O
considered	O
inappropriate	O
in	O
all	O
46	O
eyes	O
with	O
normal	O
dacryoscintillography	B:C0430022
.	O

dacryocystorhinostomy	B:C0010931
was	O
successful	O
in	O
76.5	O
%	O
,	O
however	O
,	O
the	O
dacryoscintillography	O
result	O
did	O
not	O
affect	O
the	O
success	O
of	O
surgery	O
.	O

dacryocystorhinostomy	O
was	O
successful	O
in	O
76.5	O
%	O
,	O
however	O
,	O
the	O
dacryoscintillography	B:C0430022
result	O
did	O
not	O
affect	O
the	O
success	O
of	O
surgery	O
.	O

Conclusion	O
dacryoscintillography	B:C0430022
has	O
severe	O
limitations	O
due	O
to	O
lack	O
of	O
correlation	O
with	O
symptoms	O
and	O
clinical	O
examination	O
,	O
inability	O
to	O
separate	O
lacrimal	O
duct	I:C3854333
narrowing	I:C3854333
from	O
lacrimal	O
pump	O
function	O
,	O
and	O
inability	O
to	O
predict	O
the	O
results	O
of	O
surgery	O
.	O

Conclusion	O
dacryoscintillography	O
has	O
severe	O
limitations	O
due	O
to	O
lack	O
of	O
correlation	O
with	O
symptoms	B:C1457887
and	O
clinical	O
examination	O
,	O
inability	O
to	O
separate	O
lacrimal	O
duct	I:C3854333
narrowing	I:C3854333
from	O
lacrimal	O
pump	O
function	O
,	O
and	O
inability	O
to	O
predict	O
the	O
results	O
of	O
surgery	O
.	O

Conclusion	O
dacryoscintillography	O
has	O
severe	O
limitations	O
due	O
to	O
lack	O
of	O
correlation	O
with	O
symptoms	O
and	O
clinical	O
examination	O
,	O
inability	O
to	O
separate	O
lacrimal	B:C3854333
duct	I:C3854333
narrowing	I:C3854333
from	O
lacrimal	O
pump	O
function	O
,	O
and	O
inability	O
to	O
predict	O
the	O
results	O
of	O
surgery	O
.	O

dacryoscintillography	B:C0430022
can	O
at	O
best	O
provide	O
limited	O
guidance	O
on	O
whether	O
to	O
proceed	O
to	O
DCR	O
surgery	I:C0010931
.	O

dacryoscintillography	O
can	O
at	O
best	O
provide	O
limited	O
guidance	O
on	O
whether	O
to	O
proceed	O
to	O
DCR	B:C0010931
surgery	I:C0010931
.	O

